Subgroup analysis stratified by treatment regimen revealed that the same cutoff value predicted a trend toward longer survival in patients receiving combination therapy; however, the results did not reach statistical significance for OS (PFS: p = 0.04, OS: p = 0.06).
← all excerpts
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8<sup>+</sup> T cells as a predictor of clinical benefit.
1
0.0400
0.0400